Article Details

BioAtla Conditionally Active Biologic Antibody Design And Functionality For Cancer Treatment ...

Retrieved on: 2021-02-22 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

BioAtla Conditionally Active Biologic Antibody Design And Functionality For Cancer Treatment .... View article details on hiswai:

Excerpt

Utilizing its proprietary Conditionally Active Biologics (CAB) technology, BioAtla develops novel monoclonal antibody and other protein therapeutic ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo